The results obtained by El-Shenawy (2010) showed a significant increase in ALT and AST leakage when the hepatocytes were incubated with 10 and 100 μM ABA for 30–120 min (final period of sample collection). Necrosis and apoptosis are types of cell death. One evident physiological difference in cells undergoing apoptosis versus necrosis is in the intracellular levels of ATP. Whereas necrotic cell death occurs in the absence of ATP, apoptosis depends on intracellular

ATP levels (Tsujimoto, 1997). Many key events in apoptosis focus on the mitochondria, including the release of caspase activators (such as cytochrome c), changes in electron transport, loss of mitochondrial transmembrane see more potential, altered cellular oxidation–reduction, and participation of pro- and antiapoptotic Bcl-2 family proteins ( Green and Reed, 1998). Depsipeptide supplier Thus, in this study, the parameters related to both types of cell death were monitored, allowing the type of cell death triggered by ABA in isolated hepatocytes to be distinguished. The release of cytochrome c and caspase 3 activity are steps in determining apoptosis establishment for the intrinsic pathway ( Kass et al., 1996 and Barros et al., 2003). For both parameters, we have not found significant variation in apoptosis induction

in hepatocytes exposed to ABA. Necrosis is characterized by changes that cause MycoClean Mycoplasma Removal Kit depletion of ATP, disruption of ionic equilibrium, swelling of mitochondria and the cell, and activation of degradative enzymes. These changes result in the disruption of the plasma membrane and loss of proteins, intracellular metabolites

and ions (Eguchi et al., 1997, Nicotera et al., 1998 and Lemasters et al., 1999). Following microscopic evaluation of Hoechst-propidium-iodide double staining, it was confirmed that ABA induces necrosis, which was initially observed at 60 min in a concentration- and time-dependent manner upon the addition of 75 and 100 μM of ABA and that proadifen stimulated this effect. This study indicates that the mechanism of ABA hepatotoxicity involves an effect on mitochondrial bioenergetics and alteration in calcium homeostasis, which leads to a decrease in ATP synthesis with consequent cell death by necrosis (Fig. 8). Furthermore, this study shows that the metabolism of ABA, which is performed by cytochrome P450 in the liver, influences its toxicity. For all variables evaluated, there was an increase in the toxic potential of ABA in the presence of proadifen, indicating that the parent drug has greater potential than the metabolites. The authors declare that there are no conflicts of interest. This work was supported by grants from Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), Processes numbers 2010/08570-2 and 2010/03791-0, Brazil.